Stockscreener 앱 받기
1.01
2.88%
-0.03
시간 외 거래:
1.01
전일 마감가:
$1.04
열려 있는:
$1
하루 거래량:
1.27M
Relative Volume:
0.27
시가총액:
$145.45M
수익:
-
순이익/손실:
$-119.76M
주가수익비율:
-0.7481
EPS:
-1.35
순현금흐름:
$-55.17M
1주 성능:
-22.31%
1개월 성능:
+1.00%
6개월 성능:
+119.37%
1년 성능:
-89.09%
1일 변동 폭
$0.96
$1.09
1주일 범위
$0.96
$1.305
52주 변동 폭
$0.295
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
명칭
Applied Therapeutics Inc
전화
212-220-9226
주소
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
APLT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
1.01 | 149.77M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-23 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-11-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | 개시 | William Blair | Outperform |
| 2024-03-26 | 개시 | RBC Capital Mkts | Outperform |
| 2024-02-22 | 개시 | Leerink Partners | Outperform |
| 2022-01-04 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-08-27 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-06-25 | 재개 | Goldman | Neutral |
| 2020-10-08 | 개시 | Truist | Buy |
| 2020-04-22 | 개시 | Goldman | Buy |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2019-06-10 | 개시 | Citigroup | Buy |
| 2019-06-10 | 개시 | Cowen | Outperform |
| 2019-06-10 | 개시 | Robert W. Baird | Outperform |
모두보기
Applied Therapeutics Inc 주식(APLT)의 최신 뉴스
Custom watchlist performance reports with Applied Therapeutics Inc.2025 Growth vs Value & Free Risk Controlled Daily Trade Plans - newser.com
Analyzing Applied Therapeutics Inc. with multi timeframe chartsJuly 2025 Trade Ideas & AI Powered Market Entry Ideas - newser.com
Can a trend reversal in Applied Therapeutics Inc. lead to recoveryQuarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Does Applied Therapeutics Inc. show high probability of reboundCPI Data & Expert Approved Momentum Ideas - newser.com
Volume spikes in Applied Therapeutics Inc. stock – what they meanJuly 2025 Retail & Weekly High Return Stock Opportunities - newser.com
News impact scoring models applied to Applied Therapeutics Inc.2025 Earnings Surprises & Verified High Yield Trade Plans - newser.com
Real time alert setup for Applied Therapeutics Inc. performanceChart Signals & Daily Entry Point Alerts - newser.com
What makes Applied Therapeutics Inc. stock attractive to growth funds2025 Top Decliners & Technical Confirmation Trade Alerts - newser.com
Applied Therapeutics Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Is Applied Therapeutics Inc. (2UV) stock among top earnings playsQuarterly Growth Report & Verified Short-Term Trading Plans - newser.com
Can Applied Therapeutics Inc. (2UV) stock ride next bull market cycleJuly 2025 Intraday Action & AI Enhanced Execution Alerts - newser.com
Can Applied Therapeutics Inc. (2UV) stock double in coming yearsDividend Hike & Expert-Curated Trade Recommendations - newser.com
Can Applied Therapeutics Inc. (2UV) stock surprise markets with earnings2025 Institutional Moves & Growth Focused Investment Plans - newser.com
Applied Therapeutics Inc. stock daily chart insightsWeekly Trade Recap & Risk Controlled Swing Trade Alerts - newser.com
Will Applied Therapeutics Inc. stock recover faster than peersQuarterly Investment Review & Free Reliable Trade Execution Plans - newser.com
Statistical indicators supporting Applied Therapeutics Inc.’s strengthWall Street Watch & Expert Curated Trade Setups - newser.com
How geopolitical tensions affect Applied Therapeutics Inc. stockTrade Risk Report & Weekly Sector Rotation Insights - newser.com
Why Applied Therapeutics Inc. (2UV) stock is a must watch tickerChart Signals & Daily Entry Point Alerts - newser.com
Applying big data sentiment scoring on Applied Therapeutics Inc.Rate Cut & High Return Trade Opportunity Guides - newser.com
Is Applied Therapeutics Inc. stock a good choice for value investorsMarket Performance Recap & Weekly Return Optimization Alerts - newser.com
Are Analysts Too Optimistic About Bajaj Consumer Care Limiteds Revenue GrowthMarket Breadth Indicators & Low Cost Trading Plans - earlytimes.in
What data driven models say about Applied Therapeutics Inc.’s futureMarket Growth Summary & Real-Time Volume Analysis - newser.com
What does recent volatility data suggest for Applied Therapeutics Inc.Entry Point & Short-Term Trading Opportunity Alerts - newser.com
Applied Therapeutics (APLT) Projected to Post Earnings on Thursday - MarketBeat
Applied Therapeutics Inc (APLT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Applied Therapeutics Inc 주식 (APLT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Funtleyder Leslie D. | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
14,502 |
6,381 |
390,459 |
| Chinoporos Constantine | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
447 |
197 |
271,436 |
| Funtleyder Leslie D. | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
22,950 |
14,000 |
404,961 |
| Perfetti Riccardo | Chief Medical Officer |
Feb 06 '25 |
Sale |
0.61 |
86,078 |
52,508 |
900,775 |
| Chinoporos Constantine | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
28,117 |
17,151 |
271,883 |
1.45%
0.86%
자본화:
|
볼륨(24시간):